HUP9900239A2 - Módosított avidin és streptavidinszármazékok - Google Patents

Módosított avidin és streptavidinszármazékok

Info

Publication number
HUP9900239A2
HUP9900239A2 HU9900239A HUP9900239A HUP9900239A2 HU P9900239 A2 HUP9900239 A2 HU P9900239A2 HU 9900239 A HU9900239 A HU 9900239A HU P9900239 A HUP9900239 A HU P9900239A HU P9900239 A2 HUP9900239 A2 HU P9900239A2
Authority
HU
Hungary
Prior art keywords
streptavidin molecules
modified avidin
avidin
modified
streptavidin
Prior art date
Application number
HU9900239A
Other languages
English (en)
Inventor
Edward A. Bayer
Ely Morag
Meir Wilchek
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of HUP9900239A2 publication Critical patent/HUP9900239A2/hu
Publication of HUP9900239A3 publication Critical patent/HUP9900239A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/77—Ovalbumin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
HU9900239A 1995-06-14 1996-06-13 Modified avidin and streptavidin molecules and use thereof HUP9900239A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11414995A IL114149A0 (en) 1995-06-14 1995-06-14 Modified avidin and streptavidin molecules and use thereof

Publications (2)

Publication Number Publication Date
HUP9900239A2 true HUP9900239A2 (hu) 1999-05-28
HUP9900239A3 HUP9900239A3 (en) 1999-11-29

Family

ID=11067612

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900239A HUP9900239A3 (en) 1995-06-14 1996-06-13 Modified avidin and streptavidin molecules and use thereof

Country Status (14)

Country Link
US (1) US5973124A (hu)
EP (1) EP0871658B1 (hu)
JP (1) JPH11507920A (hu)
KR (1) KR19990022896A (hu)
CN (1) CN1119353C (hu)
AT (1) ATE481417T1 (hu)
AU (1) AU713417B2 (hu)
BR (1) BR9609241A (hu)
CA (1) CA2221647A1 (hu)
CZ (1) CZ401697A3 (hu)
DE (1) DE69638257D1 (hu)
HU (1) HUP9900239A3 (hu)
IL (1) IL114149A0 (hu)
WO (1) WO1997000329A2 (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19637718A1 (de) * 1996-04-01 1997-10-02 Boehringer Mannheim Gmbh Rekombinante inaktive Core-Streptavidin Mutanten
AU6701498A (en) 1997-03-14 1998-09-29 Trustees Of Boston University Multiflavor streptavidin
US6391571B1 (en) 1997-04-01 2002-05-21 Roche Diagnostics Gmbh Recombinant inactive avidin mutants
US5985658A (en) * 1997-11-14 1999-11-16 Health Research Incorporated Calmodulin-based cell separation technique
DE69931467T3 (de) * 1998-11-06 2018-12-27 Lsi Medience Corporation Neue komplexe, die vernetztes avidin enthalten, verfahren zur herstellung und analyseverfahren, das diese verwendet
IL126991A0 (en) 1998-11-10 1999-09-22 Yeda Res & Dev Azobenzene derivatives and intermediates thereof
WO2000027814A1 (en) * 1998-11-10 2000-05-18 Yeda Research And Development Co. Ltd. Avidin derivatives and uses thereof
AU778776B2 (en) * 1999-04-14 2004-12-23 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The High sensitivity phage display biomolecule detection
WO2001009141A1 (fr) * 1999-07-29 2001-02-08 National Institute Of Advanced Industrial Science And Technology Derives de biotine polymerisables, polymere de la biotine et polymere reagissant a la stimulation de l'avidine
JP2004501110A (ja) * 2000-05-23 2004-01-15 ネクセル　セラピューティックス　インコーポレイティド 細胞選択用試薬および使用方法
GB0102568D0 (en) 2001-02-01 2001-03-21 Magnetic Biosolutions Sweden A Method
US7754155B2 (en) * 2002-03-15 2010-07-13 Ross Amelia A Devices and methods for isolating target cells
US20030175818A1 (en) * 2002-03-15 2003-09-18 Ross Amelia A. Devices and methods for isolating and recovering target cells
US8426028B2 (en) * 2004-04-28 2013-04-23 University Of Houston Preparation of sensors on oligo- or poly (ethylene glycol) films on silicon surfaces
US9302242B2 (en) * 2004-04-28 2016-04-05 University Of Houston System Preparation of nanometric arrays of biomolecules on oligo- or poly(ethylene glycol) films on silicon surfaces
WO2006086019A2 (en) * 2004-10-21 2006-08-17 Optiscan Biomedical Corporation Methods of treating diabetes
WO2006084388A1 (en) * 2005-02-11 2006-08-17 Uti Limited Partnership Monomeric streptavidin muteins
US20070025918A1 (en) * 2005-07-28 2007-02-01 General Electric Company Magnetic resonance imaging (MRI) agents: water soluble carbon-13 enriched fullerene and carbon nanotubes for use with dynamic nuclear polarization
US7704708B2 (en) * 2006-02-13 2010-04-27 Uti Limited Partnership Monomeric streptavidin muteins
EP2230264B1 (en) 2006-06-29 2019-10-09 Life Technologies AS Particles containing multi-block polymers
AU2007353319A1 (en) * 2006-11-15 2008-11-20 Invitrogen Dynal As Methods for reversibly binding a biotin compound to a support
US8506993B2 (en) * 2007-08-14 2013-08-13 University Of Houston Compositions and methods for making and using multifunctional polymerized liposomes
US7842475B2 (en) * 2008-01-08 2010-11-30 Siemens Healthcare Diagnostics Inc. Stabilization of solid support assay reagents
US20090209447A1 (en) * 2008-02-15 2009-08-20 Michelle Meek Cleaning compositions
TWI365185B (en) * 2008-07-24 2012-06-01 Lilly Co Eli Amidophenoxyindazoles useful as inhibitors of c-met
DE102008053892A1 (de) 2008-10-30 2010-05-06 Fachhochschule Gelsenkirchen Medizinisches Implantat mit biofunktionalisierter Oberfläche
CN105051270B (zh) 2013-03-15 2019-05-07 代表亚利桑那大学的亚利桑那校董会 生物传感器微阵列构成和方法
AU2014232882B2 (en) 2013-03-15 2018-03-22 Hycor Biomedical, Inc. Automated immunoanalyzer system for performing diagnostic assays for allergies and autoimmune diseases
WO2015195404A1 (en) 2014-06-20 2015-12-23 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for detection of an analyte by movement of tethered microparticles
WO2016205239A1 (en) 2015-06-15 2016-12-22 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Non-hormonal mammalian sperm decoy contraception based on the n-terminus of the zp2 protein
EP3529205B1 (en) 2016-10-21 2022-06-15 The United States of America, as represented by the Secretary, Department of Health and Human Services Molecular nanotags

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2184386C (en) * 1994-03-05 2005-10-18 Rosemarie Kientsch-Engel Interference eliminating agent for application in immunoassays

Also Published As

Publication number Publication date
EP0871658A4 (en) 2002-12-04
EP0871658B1 (en) 2010-09-15
DE69638257D1 (de) 2010-10-28
WO1997000329A3 (en) 1997-03-06
CZ401697A3 (cs) 1998-07-15
US5973124A (en) 1999-10-26
KR19990022896A (ko) 1999-03-25
WO1997000329A2 (en) 1997-01-03
AU713417B2 (en) 1999-12-02
CN1191018A (zh) 1998-08-19
BR9609241A (pt) 1999-10-13
MX9710181A (es) 1998-03-31
JPH11507920A (ja) 1999-07-13
IL114149A0 (en) 1995-10-31
CN1119353C (zh) 2003-08-27
CA2221647A1 (en) 1997-01-03
EP0871658A2 (en) 1998-10-21
HUP9900239A3 (en) 1999-11-29
ATE481417T1 (de) 2010-10-15
AU6135396A (en) 1997-01-15

Similar Documents

Publication Publication Date Title
HUP9900239A3 (en) Modified avidin and streptavidin molecules and use thereof
IL122428A0 (en) Minizymes and minribozymes and uses thereof
GB2298422B (en) Compounds and their use
EP0902834A4 (en) STABLE AVIDIN COMPOSITION AND METHODS OF USE THEREOF
IL122392A0 (en) Structurally determined metallo-constructs and applications
EP0815121A4 (en) MODIFIED AFFINITY STREPTAVIDINE
IL119317A (en) Dram system and operation thereof
EP0768038A3 (en) Shortening and its use
EP0851759A4 (en) COMPOUNDS AND RELATED METHODS
HUP9802303A3 (en) Calcitriol derivatives and their uses
EP0832111A4 (en) MODIFIED AVIDIN AND STREPTAVIDIN AND METHODS FOR THEIR USE
EP0836617A4 (en) PAREVINES AND TACHYTEGRINES
ZA964862B (en) Optimized minizymes and miniribozymes and uses thereof
EP0817817A4 (en) ICE-PREGNATING MOLECULES AND THEIR USE
GB9518154D0 (en) Oligonucleotides and their use
EP0744125A3 (en) Iodine complex and its application
GB9606882D0 (en) Signal and support structure
GB9504077D0 (en) Catalyst and its use
GB2297502B (en) Harvester-knife cylinder and blower-assist
IL122444A0 (en) Modified avidin and streptavidin molecules and use thereof
GB9526407D0 (en) Substances and their uses
GB9501868D0 (en) Assays and uses thereof
GB9402494D0 (en) Music accompaniment and teaching system
GB9500898D0 (en) Substances and their uses
GB9507541D0 (en) Substances and their uses